Botox vs Xeomin: What's the Difference?

Botox vs Xeomin at a Glance

FDA-approved indications reflect current labeling at time of review and are subject to change. Formulation, onset, and duration entries should be verified against current prescribing information. This table is educational and is not a substitute for product labeling or provider counseling.

What Is Botox Cosmetic?

Botox Cosmetic (onabotulinumtoxinA) is a prescription injectable neuromodulator made with botulinum toxin type A. It is used to temporarily reduce targeted muscle activity that contributes to selected expression-related lines. According to current FDA labeling, Botox Cosmetic is approved for the temporary improvement in the appearance of moderate to severe glabellar lines, lateral canthal lines (crow's feet), and forehead lines in adults.

Botox Cosmetic is manufactured by AbbVie/Allergan. It has been studied extensively and has a long clinical track record. Dosing is product-specific. For a full overview of how Botox is used at Youthful Magnolia, see our Botox treatment page.

What Is Xeomin?

Xeomin (incobotulinumtoxinA) is a prescription injectable neuromodulator made with botulinum toxin type A. According to current FDA labeling, Xeomin is approved for the temporary improvement in the appearance of moderate to severe glabellar lines (the vertical frown lines between the brows) in adults. Xeomin is also approved for certain therapeutic (non-cosmetic) indications.

Xeomin is manufactured by Merz Pharmaceuticals. It is not generic Botox — it is a distinct prescription product with its own formulation, labeling, and dosing system. For a full overview of how Xeomin is used at Youthful Magnolia, see our Xeomin treatment page.

What's the Biggest Difference Between Botox and Xeomin?

The most commonly discussed formulation difference involves accessory (complexing) proteins. Botox Cosmetic (onabotulinumtoxinA) contains accessory proteins as part of its formulation. Xeomin (incobotulinumtoxinA) is formulated without accessory (complexing) proteins.

We use exact FDA and manufacturer terminology rather than marketing shorthand. This formulation difference is real, but it does not automatically mean one product is safer, more effective, more natural, or better for sensitive patients. The clinical significance of this difference is discussed in the peer-reviewed literature and requires medical review.

Is Xeomin Really "Naked Botox"?

"Naked Botox" is a marketing nickname, not a precise medical term. Xeomin and Botox are distinct prescription products made by different manufacturers. The nickname refers to Xeomin being formulated without accessory (complexing) proteins, but that is a formulation distinction — not a purity ranking.

We avoid inflammatory wording. The absence or presence of certain complexing proteins does not make one product "clean" and the other "dirty." Both are FDA-approved prescription medications manufactured to regulatory standards.

Is Xeomin Purer Than Botox?

We avoid framing one product as clinically "purer" in a way that implies superior safety or effectiveness. The formulation difference (accessory proteins) is factual, but we do not equate fewer accessory proteins with safer, healthier, more natural, toxin-free, or better for sensitive patients unless evidence explicitly supports a specific claim.

Both products are prescription medications approved by the FDA. "Purity" in this context is a formulation characteristic, not a clinical superiority ranking. This section requires medical review against current evidence.

Are Botox and Xeomin Units the Same?

No. This is one of the most important things to understand.

Each product uses its own biological potency assay and labeled dosing system. The units printed on a treatment chart or syringe are product-specific — they measure how each manufacturer has standardized its own product. They cannot be compared directly between the two products.

We do not publish a universal conversion ratio. Even if literature discusses practical ratios, we do not turn those into patient-facing dosing instructions. For a deeper look at how Botox dosing works by treatment area, see our Botox unit guide.

Why You Shouldn't Convert Botox Units to Xeomin Units Yourself

Dosing is product-specific. Treatment areas differ, muscle strength differs, anatomy differs, and FDA indications differ. A unit number from a Botox treatment cannot be mechanically translated into a Xeomin unit number.

We do not provide formulas, calculators, or conversion tables. Product selection and dosing should be guided by your provider, not by unit arithmetic.

Which Works Faster: Botox or Xeomin?

We do not choose a universal onset winner. Some studies and product information may report differences in when effects become noticeable, but individual experience varies. Onset can vary by:

• individual response
• treatment area
• dose
• study definition
• product

We do not say Xeomin always works faster. We do not say Botox always works faster. Your provider can discuss what to expect based on current product information and your anatomy.

Botox vs Xeomin Results Timeline

For both products, results develop gradually rather than instantly. Effects become noticeable over a period of days, with continued development over the following weeks. The specific timeline depends on the product, treatment area, dose, and your individual response.

We avoid publishing a single generic timeline because official product information and individual experience vary. It is helpful to distinguish between onset (when effects first become noticeable), development of effect, and duration (how long the effect is maintained).

Which Lasts Longer: Botox or Xeomin?

Neither should be presented as universally longer-lasting. Duration varies by:

• patient
• muscle
• dose
• treatment area
• individual biological response

We use clinical data carefully and do not turn median or study data into guarantees. If you have seen common duration ranges described as "3–4 months," verify them against current official information and medical review. We do not write "Botox lasts exactly 3 months" or "Xeomin lasts exactly 4 months." Duration is patient-specific.

Botox vs Xeomin for Forehead Lines

Botox Cosmetic is FDA-approved for moderate to severe forehead lines. Xeomin is FDA-approved for glabellar lines; use of Xeomin in the forehead is off-label.

We clearly distinguish FDA-approved uses from off-label uses. Off-label use may be medically appropriate when determined by a qualified provider based on individual anatomy and goals, but it is not the same as an FDA-approved indication. Forehead treatment also requires care because the muscles that raise the brow interact with the muscles that pull it down. The right product for your forehead depends on anatomy, muscle strength, desired movement, and provider judgment.

Botox vs Xeomin for Frown Lines

The glabellar area — the vertical lines between the brows often called "frown lines" or "11s" — is a cosmetic area where both Botox Cosmetic and Xeomin are FDA-approved.

Both products are indicated for the temporary improvement of moderate to severe glabellar lines. The right choice depends on individual muscle strength, anatomy, prior response, and treatment goals. Neither is universally better for frown lines. We do not assume dosing equivalence — dosing is product-specific and individualized.

Botox vs Xeomin for Crow's Feet

Botox Cosmetic is FDA-approved for moderate to severe lateral canthal lines (crow's feet). Xeomin is FDA-approved for glabellar lines; use of Xeomin for crow's feet is off-label.

Again, we clearly distinguish FDA-approved uses from off-label uses. Off-label use may be medically appropriate when determined by a qualified provider based on individual anatomy and goals, but it is not the same as an FDA-approved use. The right choice for crow's feet depends on anatomy and goals, determined at consultation.

Can Botox and Xeomin Be Used in Other Facial Areas?

Beyond the FDA-approved cosmetic indications discussed above, neuromodulators may be used off-label in selected areas by qualified clinicians. These may include brow positioning, bunny lines, chin dimpling, lip flip, platysmal bands, masseter, and gummy smile.

Many of these uses are off-label for both products. We do not create a treatment map, give injection coordinates, or provide doses. Whether a specific area is appropriate for you requires individualized assessment at consultation.

Which Looks More Natural: Botox or Xeomin?

The product brand alone does not determine whether results look natural. Natural-looking outcomes depend primarily on:

• treatment plan
• dose
• anatomy
• placement
• desired movement
• provider judgment

Either product can produce natural-looking results when placed thoughtfully, and either can look unnatural if poorly planned. The provider and the plan matter more than the brand name.

Is Xeomin Less Likely to Make You Look Frozen?

We do not support this as a general claim. An overly restricted or "frozen" appearance relates more to treatment planning and dosing than to the brand. Either product can preserve natural movement when dosed conservatively, and either can restrict movement if dosed aggressively.

"Frozen" is not an inherent property of either product. It is a result of how the product is dosed and placed. This section requires medical review.

Does Xeomin Spread Differently Than Botox?

We handle this carefully. We do not repeat broad marketing claims such as "Botox stays exactly where placed," "Xeomin spreads less," or "one spreads more naturally." Diffusion depends on multiple variables:

• formulation
• dose
• concentration
• anatomy
• injection technique

We keep technical details limited and medically reviewed. This section requires medical review.

Is Xeomin Stronger Than Botox?

We do not frame strength through unit numbers alone. Units are product-specific. Clinical effectiveness depends on appropriate dose, indication, treatment plan, and individual response.

A higher unit number does not mean more strength. A lower unit number does not mean less strength. Neither is universally "stronger."

Can You Become Resistant to Botox or Xeomin?

Diminished clinical response can have multiple explanations. True neutralizing-antibody resistance is a medical issue. Product formulation may be discussed in the literature, but we do not self-diagnose resistance.

If you feel your results have changed, a provider should reassess before assuming antibody resistance. This section requires medical review.

Is Xeomin Less Likely to Cause Antibody Resistance?

We do not state this as settled fact unless current evidence supports the exact claim. The theoretical and clinical discussion around accessory proteins and immunogenicity is complex.

We use peer-reviewed evidence and do not convert mechanistic theory into a patient guarantee. The formulation difference (Xeomin being without accessory proteins) is discussed in the literature, but we do not promise that Xeomin prevents resistance. This requires medical review against current evidence.

What If Botox Seems Like It Stopped Working?

Possible considerations include:

• treatment timing
• dose
• muscle pattern
• product response
• expectations
• true secondary nonresponse

We do not diagnose. A provider should reassess before assuming antibody resistance. Whether switching to Xeomin is appropriate is an individualized clinical decision — not a self-directed fix.

Can You Switch From Botox to Xeomin?

Yes, clinicians may use different neuromodulator products over time when appropriate. However:

• the treatment plan should be reassessed
• units are not automatically transferred
• a previous dose should not be copied mechanically

We do not provide conversion instructions. Your provider adjusts the plan based on your history and goals.

Can You Switch Back to Botox After Xeomin?

Generally, product choice can be reassessed over time. Patients may return to Botox or switch to another neuromodulator under clinician guidance.

We use medically reviewed language and do not imply frequent switching is inherently beneficial. Treatment timing should be determined by your provider based on when the prior treatment's effects have sufficiently resolved.

Is Botox or Xeomin Better for First-Time Patients?

We do not choose universally. First-time product selection can depend on:

• treatment area
• provider familiarity
• movement pattern
• goals
• current product availability
• medical history

Brand should not replace anatomical assessment. The product follows the plan — not the other way around.

Botox vs Xeomin Cost

We do not assume one product is cheaper, and we do not use competitor pricing. If Youthful Magnolia pricing is not verified for a given product, we explain that total treatment cost depends on:

• current product price
• product-specific dosing
• areas treated
• individualized plan

We do not list specific pricing online. Schedule a consultation for current treatment recommendations and pricing. For a full guide to Botox pricing and cost factors, see our Botox cost article.

Why Comparing Botox and Xeomin by Price Per Unit Can Be Misleading

Because units are product-specific, price-per-unit comparisons can be misleading when separated from recommended dose, treatment area, total cost, and treatment duration.

A product priced lower per unit does not automatically mean the total treatment is cheaper, because the unit systems differ. We do not publish unit conversion formulas.

What Matters More Than the Price Per Unit?

Total treatment price, treatment plan, expected response, provider experience, follow-up, and your goals all matter more than the per-unit price. The most informed way to compare cost is to discuss your treatment plan and total investment with your provider.

Is Botox or Xeomin Cheaper Over Time?

We do not create a universal annual cost. Long-term cost depends on:

• dose
• treatment frequency
• current pricing
• individual duration
• treatment area

We do not assume equal intervals. The most informed approach is to discuss your treatment plan and total investment with your provider.

So Which Is Better: Botox or Xeomin?

Neither is universally better. The decision should be based on:

• anatomy
• movement
• treatment area
• past response
• desired degree of movement
• medical history
• provider experience
• cost considerations

We avoid winner/loser framing. The most useful question is not "which brand is better?" but "which product and plan fit your anatomy and goals?"

Is One Better for Subtle Results?

We do not attribute subtlety primarily to brand. Subtle results are usually determined by:

• dose
• placement
• treatment plan
• baseline muscle strength
• desired movement

Either product may potentially be used conservatively when appropriate. The plan matters more than the brand.

Does Stronger Facial Movement Mean You Need Botox Instead of Xeomin?

No universal rule. Muscle strength can affect dosing, but does not automatically determine brand. We do not create a dosing guide. Product selection is individualized based on anatomy and goals.

Botox vs Xeomin for Men

Men may sometimes have stronger or larger facial muscles, but sex alone does not determine product, dose, or outcome. We avoid gender stereotypes. Product selection is individualized based on anatomy, movement, and goals — not on gender alone.

Does Age Affect Whether Botox or Xeomin Is Better?

Age alone is not the deciding factor. More relevant factors include:

• dynamic vs etched lines
• muscle activity
• skin quality
• anatomy
• treatment goals

We avoid suggesting everyone should start at a particular age. Candidacy depends on anatomy and goals, not a number.

What If the Lines Are Visible Even When Your Face Is at Rest?

Neuromodulators primarily affect muscle activity. Established static lines — lines visible at rest — may not fully disappear from neuromodulator treatment alone. Other skin treatments may sometimes be considered, but we do not aggressively upsell. This is a realistic expectation point, not a sales pivot.

Botox vs Xeomin vs Dysport: Is There a Best Neuromodulator?

There is no universally best product. Dysport (abobotulinumtoxinA) is another botulinum toxin type A neuromodulator with its own dosing and clinical profile. For a detailed comparison, see our Botox vs Dysport article. We do not recreate that comparison here.

What About Daxxify?

Daxxify (daxibotulinumtoxinA-lanm) is another prescription botulinum toxin type A product with its own formulation, labeling, dosing, and duration data. For a detailed comparison, see our Botox vs Daxxify article. We do not expand into a four-product mega article.

Do You Need to Stay With the Same Neuromodulator Forever?

No. Product choice can be reassessed based on response, goals, and clinical judgment. However, we do not suggest product-hopping is beneficial by itself. Switching does not guarantee a better response.

Are Botox and Xeomin Safe?

Both are FDA-approved prescription medications with established safety profiles when used as labeled by qualified providers. However, "safe" is not the same as "free of risk."

We do not say either product is risk-free. We do not imply Xeomin is safer because of its formulation. For complete safety information, review the prescribing information for Botox Cosmetic and Xeomin, and discuss any concerns with your provider.

Botox vs Xeomin Side Effects

Because Botox and Xeomin are different products, their prescribing information differs. We do not reproduce exhaustive package-insert language here. Possible categories may include injection-site effects, headache where supported, eyelid/brow effects where relevant, and other labeled adverse events.

For complete safety information, review the official prescribing information for each product and discuss any concerns with your provider. If you experience any serious symptoms after treatment, seek immediate medical attention. This section requires medical review.

Who Should Not Receive Botox or Xeomin?

Each product has contraindications described in its FDA prescribing information. These may include allergy to the product or to other botulinum toxin products, skin infection at the planned injection site, and certain underlying neuromuscular conditions.

We do not simplify contraindications from memory. Whether you are a candidate for either product requires individualized assessment by a qualified provider who reviews your medical history. This section requires medical review.

What Should You Tell Your Injector Before Treatment?

Potential topics include:

• neuromuscular conditions
• medications
• previous botulinum toxin treatments
• allergies
• pregnancy/breastfeeding
• treatment history

We do not create a substitute for medical screening. This information is reviewed with your provider before any treatment.

How Youthful Magnolia Chooses Between Botox and Xeomin

At Youthful Magnolia, product selection is individualized. We do not force one brand. Factors we consider include:

• anatomy
• movement
• prior response
• treatment area
• desired movement
• product history
• patient preference

The product follows the plan — not the other way around.

Botox and Xeomin at Youthful Magnolia in Fort Worth

At Youthful Magnolia in Fort Worth, product selection is based on consultation, facial movement, anatomy, previous treatment response, and patient goals. Every neuromodulator consultation is led personally by Amy Robbins, who approaches treatment planning with clinical nuance and honesty about what is realistically achievable. We do not default to whichever product is most marketed.